0001209191-22-013207.txt : 20220225
0001209191-22-013207.hdr.sgml : 20220225
20220225163941
ACCESSION NUMBER: 0001209191-22-013207
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220224
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Surdykowski Andrew J
CENTRAL INDEX KEY: 0001755922
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36198
FILM NUMBER: 22680993
MAIL ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE
CITY: ATLANTA
STATE: GA
ZIP: 30328
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intercontinental Exchange, Inc.
CENTRAL INDEX KEY: 0001571949
STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
BUSINESS PHONE: 770-857-4700
MAIL ADDRESS:
STREET 1: 5660 NEW NORTHSIDE DRIVE,
STREET 2: THIRD FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30328
FORMER COMPANY:
FORMER CONFORMED NAME: IntercontinentalExchange Group, Inc.
DATE OF NAME CHANGE: 20130313
FORMER COMPANY:
FORMER CONFORMED NAME: Intercontinental Exchange Group, Inc.
DATE OF NAME CHANGE: 20130312
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-24
0
0001571949
Intercontinental Exchange, Inc.
ICE
0001755922
Surdykowski Andrew J
5660 NEW NORTHSIDE DRIVE
ATLANTA
GA
30328
0
1
0
0
General Counsel
Common Stock
2022-02-24
4
G
0
200
0.00
D
44897
D
Common Stock
2022-02-24
4
S
0
200
121.305
D
44697
D
Common Stock
2022-02-24
4
S
0
600
124.1883
D
44097
D
Common Stock
2022-02-24
4
S
0
800
125.4425
D
43297
D
Common Stock
2022-02-24
4
S
0
547
126.5739
D
42750
D
Common Stock
2022-02-24
4
S
0
375
127.8417
D
42375
D
This transaction involved a gift of 200 shares of the issuer's common stock by the reporting person to a philanthropic organization.
The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.
The price range for the aggregate amount sold by the direct holder is $121.22 - $121.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $123.99 - $124.32. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $125.10 - $125.64. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $126.19 - $126.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The price range for the aggregate amount sold by the direct holder is $127.31 - $128.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
The common stock number referred in Table I is an aggregate number and represents 35,992 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.
/s/ Octavia N. Spencer, Attorney-in-fact
2022-02-25